Related references
Note: Only part of the references are listed.The SIX1-EYA transcriptional complex as a therapeutic target in cancer
Melanie A. Blevins et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Six1: A critical transcription factor in tumorigenesis
Wangjun Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
Manoj M. Pillai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Genome-Wide Analysis of miRNA-mRNA Interactions in Marrow Stromal Cells
Ilango Balakrishnan et al.
STEM CELLS (2014)
Competition and collaboration between RNA-binding proteins and microRNAs
J. J. David Ho et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells
Linlin Xu et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
hnRNP Q regulates translation of p53 in normal and stress conditions
D-Y Kim et al.
CELL DEATH AND DIFFERENTIATION (2013)
Active Stabilization of Human Endothelial Nitric Oxide Synthase mRNA by hnRNP E1 Protects against Antisense RNA and MicroRNAs
J. J. David Ho et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome
Aaron N. Patrick et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression
Zhaoming Li et al.
PLOS ONE (2013)
The EYA-SO/SIX complex in development and disease
Pin-Xian Xu
PEDIATRIC NEPHROLOGY (2013)
The p53 miRNA interactome and its potential role in the cancer clinic
Jonathan Krell et al.
EPIGENOMICS (2013)
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
Adam D. Pfefferle et al.
GENOME BIOLOGY (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Suhaida A. Selamat et al.
GENOME RESEARCH (2012)
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
Chu-An Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The mRNA Stability Factor HuR Inhibits MicroRNA-16 Targeting of COX-2
Lisa E. Young et al.
MOLECULAR CANCER RESEARCH (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
A. L. Smith et al.
ONCOGENE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Ritsuko Iwanaga et al.
BREAST CANCER RESEARCH (2012)
Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas
Jin Zhang et al.
GENES & DEVELOPMENT (2011)
An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer
Juan Cui et al.
NUCLEIC ACIDS RESEARCH (2011)
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Espen Enerly et al.
PLOS ONE (2011)
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition
Ziping Zhang et al.
CANCER GENETICS (2011)
The multiple levels of regulation by p53 ubiquitination
J. T. Lee et al.
CELL DEATH AND DIFFERENTIATION (2010)
Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
Hongwei Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
5′-3′-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage
Jing Chen et al.
GENES & DEVELOPMENT (2010)
Mutated KRAS Results in Overexpression of DUSP4, a MAP-Kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas
Jochen Gaedcke et al.
GENES CHROMOSOMES & CANCER (2010)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
Soo Mi Kim et al.
PLOS ONE (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Signaling to p53: Ribosomal Proteins Find Their Way
Yanping Zhang et al.
CANCER CELL (2009)
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
Tao Liu et al.
CANCER LETTERS (2009)
The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease
J. P. Kumar
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L. McCoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
Douglas S. Micalizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis
Oren Ben-Ami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma et al.
BREAST CANCER RESEARCH (2009)
Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation
Ricardo D. Coletta et al.
CANCER RESEARCH (2008)
Gene expression in early stage cervical cancer
Petra Biewenga et al.
GYNECOLOGIC ONCOLOGY (2008)
p53 mrNA controls p53 activity by managing Mdm2 functions
Marco M. Candeias et al.
NATURE CELL BIOLOGY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
Xiaohong Wang et al.
PLOS ONE (2008)
The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells
Susanne U. Mertens-Talcott et al.
CANCER RESEARCH (2007)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival
Kian Behbakht et al.
CANCER RESEARCH (2007)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage
D. -Q Yang et al.
ONCOGENE (2006)
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program
NP Gomes et al.
GENES & DEVELOPMENT (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin
M Takagi et al.
CELL (2005)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation
K Mazan-Mamczarz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
P53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
YL Yin et al.
NATURE CELL BIOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein
HL Ford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
